More lawmakers stake out stances on China biotech investment
Ahead of a Democrat-led Congress next year, more lawmakers in both parties and chambers are taking fresh positions on whether the US should restrict investments in China’s booming biotech sector. As shown in multiple draft ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
- Congressional biotech commission warns of China deal flow endpoints.news
- China could ‘corner’ biopharmaceutical sector with new plan, US panel warns biopharmadive.com